Understand how this artificial intelligence is revolutionizing the concept of what an autonomous agent can do (and what risks ...

ASX-listed Austral Resources Australia has signed a nonbinding memorandum of understanding with Metal Bank to evaluate the potential toll treatment of ore at its Rocklands processing facility in ...

Backed by BMG and Liqui Moly, young South African racing driver Karabo Malemela, delivered a standout 2025 season in the BMW ///M Performance Parts Race Series, competing as part of the Pablo Clark ...

JEE Main Result 2026 will be declared on February 16. Check the steps to download scorecard, login credentials required, official details, and latest updates here.

Evolving risk profiles such as deeper underground workings, unpredictable rainfall patterns and rising energy costs, are increasingly influencing the type of pump solutions selected by mining ...

Check out our list of the best AI grading tools for teachers together with practical tips on how to effectively integrate AI in your assessment practices.

February 2026 marks one year since Vishaal Lutchman assumed the role of Group CEO of GIBB Holdings (GIBB) - a year marked by curiosity over certainty. In an environment often driven by quick wins, ...

Seeing the rise in popularity of precious metals investments, IRAEmpire has published a new guide on IRA eligible gold to help consumers avoid confusions when it comes to buying gold in an IRA. LOS AN ...

Enento Group Plc | Stock Exchange Release | February 13, 2026 at 12:00:00 EET SUMMARYOctober - December 2025 in briefNet sales amounted to EUR 39,1 million (EUR 37,8 million), an increase of 3,3% (at ...

Stop getting amateur design. Minimum Viable Branding ensures your logo builds trust from day one. Avoid the costly mistakes of cheap branding.

Form 8.3 Announcement QUILTER PLC (Incorporated under the Companies Act 1985 with registered number 06404270 and re-registered as a public limited company under the Companies Act 2006) ISIN CODE: ...

(PRESS RELEASE) BASEL, 13-Feb-2026 — / EuropaWire / — Novartis has announced final Phase III results from the ALIGN study evaluating Vanrafia (atrasentan) in adults with IgA nephropathy (IgAN), ...